Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, November 11 at 2:00 PM ET

Register Free →

Clinical Performance Demonstration and Trial Services

Open
State & Local

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Documents

This scope was carved out of 2140688.

The full solicitation package (3 documents), including the RFP, is on the prime solicitation, not on this scope.

View the prime solicitation

BioMérieux Automated Blood Culture

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

Posted

subcontract

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Get full access to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyState University of New York (SUNY)
ContactsNo contacts available
OfficeN/A
Office AddressN/A
ContactsNo contact information available

Full Description

Show more
Performs clinical validation, demonstration, and trial installation of alternative blood culture systems for prime contractors on SUNY Upstate Medical University projects. Executes clinical demonstrations and develops supporting documentation to prove performance parity with BioMérieux standards using demonstration units and validation kits. Requires clinical laboratory expertise. Delivers performance reports and trial results.

Similar Contracts

Same NAICS industry code

NAICS: 541715
New
Federal
Area of Interest: OSW Cost Assessment and Program Evaluation (CAPE) Modeling and Simulation
Solicitation # HQ003427AOI5
The Washington Headquarters Services is soliciting innovative commercial solutions under solicitation HQ003427AOI05 to establish a next-generation modeling and simulation architecture for the Office of the Secretary of War Cost Assessment and Program Evaluation. The objective is to replace legacy infrastructure with a unified computational backbone that compresses the cycle time between budget queries and warfighting insights. This architecture must integrate three functional layers: a high-performance simulation execution layer for large-scale model runs, a machine-learned surrogate emulation layer for hosting government-developed models, and an intuitive self-service quantitative analysis layer for visualization and sensitivity analysis. The technical requirements specify a high-performance compute environment capable of executing between 1,200 simulations in 10 hours for light cases and up to 150,000 simulations within two weeks for heavy cases. The system must operate at Impact Level 6, support network throughput between 100 Mbps and 1 Gbps, and be accessible from the Pentagon and Mark Center. It must accommodate a diverse software ecosystem including Python, R, Java, PyTorch, and large language models. While the government will retain exclusive operational tenant administration and control over data and security permissions, the commercial provider will be responsible for turnkey managed IT operations, including hardware availability, patching, and cybersecurity hardening. Interested respondents must submit white papers by November 12, 2026, in accordance with Commercial Solutions Opening procedures.
Washington Headquarters Services

POSTED

about 9 hours ago

DEADLINE

in 6 days
View Details
NAICS: 541715
New
Federal
Prototype development for Battlefield Wound Infection Prevention and Treatment (BWI P&T) Barrier Combination
Solicitation # HT9427-26-R-E020
The Defense Health Agency Contracting Activity is seeking a single award to develop a Battlefield Wound Infection Prevention and Treatment Barrier Combination prototype. This medical product must integrate a physical wound barrier with antimicrobial and antifungal properties to prevent the spread of organisms and systemic infections in combat scenarios. The project aims to advance technologies starting at Technology Readiness Level 5 or higher, with the ultimate goal of achieving TRL 7 or 8. Key requirements include the execution of preclinical testing and human clinical trials, the development of Chemistry, Manufacturing, and Controls documentation, and the successful submission for FDA approval or clearance. The procurement is conducted under prototype Other Transaction Authority 10 U.S.C. 4022, meaning it utilizes a tailored agreement rather than standard FAR-based contract structures. The estimated period of performance is 48 months, divided into three primary objectives: prototype demonstration, clinical studies and regulatory submissions, and final FDA clearance. The final deliverable includes up to 50 final design prototypes for operational testing. Packaging must be individual, waterproof, and capable of being opened with gloved hands in low-light environments, while maintaining sterilization and resisting temperatures between 0 and 110 degrees Fahrenheit. Proposals are evaluated based on technical capability, management capability, and cost. Eligible participants are typically small businesses or nontraditional defense contractors; otherwise, a one-third non-federal cost share is required. Awardees must maintain active SAM registration and comply with CMMC cybersecurity frameworks and DoD instructions for Controlled Unclassified Information. Payments are processed electronically via Wide Area Workflow within 30 days of an acceptable invoice.
Defense Health Agency

POSTED

about 9 hours ago

DEADLINE

in 10 days
View Details
NAICS: 541715
New
Federal
UAS BROAD AGENCY ANNOUNCEMENT Solicitation Number: 697DCK-25-R-00278 Call 002-2027
Solicitation # 697DCK-25-R-00278
Solicitation number 697DCK-25-R-00278 is a Broad Agency Announcement issued by the Federal Aviation Administration Unmanned Aircraft Systems Integration Office to support the safe integration of Unmanned Aircraft Systems into the National Airspace System. Open through September 30, 2028, the BAA focuses on five key areas: UAS Traffic Management, Beyond-Visual-Line-of-Sight operations, industry consensus standards, electronic conspicuity, and noise and environmental impacts. The procurement utilizes a two-step process where interested parties first submit a whitepaper for preliminary consideration, and selected respondents are subsequently issued a Request for Proposal. Under Call 001A-2026, whitepapers must be submitted by April 9, 2026, and must include a Letter of Attestation from an FAA UAS Test Site, with a specific requirement for projects to partner with either the Indiana Economic Development Corporation or the Choctaw Nation of Oklahoma Emerging Aviation Technology Center. Awards are structured as cost-reimbursement contracts with no fee, requiring a minimum 1:1 cost-share where the FAA pays no more than 50 percent of the total project cost. Evaluation is based on operational readiness, mission importance, and funding availability, with a strong preference for technologies already demonstrated in an operational environment.
697DCK Regional Acquisitions Svcs

POSTED

about 9 hours ago

DEADLINE

in almost 2 years
View Details

More opportunities from State University of New York (SUNY)

Same awarding agency

NAICS: 423450
New
SLED
Acist Medical CM Injectors and Disposables
Solicitation # 2140730
Stony Brook University Hospital is seeking to purchase Acist Medical CM Injectors and Disposables under the authority of section 163(3)(vi), which allows for the procurement of commodities from a consortium or comparable entity without a formal competitive process when justified by price. This solicitation, numbered 2140730, was posted on November 10, 2026, with a response deadline of December 3, 2026. The procurement is subject to the New York State Finance Law Section 139 j&k Lobbying Law, meaning all communications must be directed exclusively to the designated procurement officers, Jessica Gruzo and Michael Assante, to avoid potential debarment or contract cancellation. Successful bidders must provide comprehensive documentation, including Vendor Responsibility forms, NYS Finance Law 139 and NYS Tax Law Section 5-a certifications, and current New York State Workers Compensation and Disability forms. While the hospital is open to discussing the procurement with vendors who manufacture equivalent products, Acist Medical Systems Inc. has been identified as a business enterprise awarded an identical or substantially similar contract within the last five years. All bids must be submitted to the Hospital Purchasing office in Ronkonkoma, New York, by the close of business on the specified due date.
Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers

POSTED

about 16 hours ago

DEADLINE

in 22 days
View Details

Earlier notices in this NAICS code

Posted before this notice, open and closed

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS